uBiome

San Francisco, United States Founded: 2012 • Age: 14 yrs
Provides comprehensive sequence datasets for human microbiome research and analysis.
Annual revenue - Latest available
Total funding $109.6M 5 rounds
Employees 33 Tracked headcount
Investors 8 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About uBiome

uBiome is a company based in San Francisco (United States) founded in 2012 by Zachary Apte and Jessica Richman. It operates as a B2B. uBiome has raised $109.62 million across 5 funding rounds from investors including OS Fund, 8VC and Y Combinator. The company has 33 employees as of December 31, 2022. uBiome operates in a competitive market with competitors including Viome, Seed, Azitra, Flore and Evvy, among others.

  • Headquarter San Francisco, United States
  • Employees 33 as on 31 Dec, 2022
  • Founders Zachary Apte, Jessica Richman
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ubiome, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $109.62 M (USD)

    in 5 rounds

  • Latest Funding Round
    $83 M (USD), Series C

    Sep 21, 2018

  • Investors
    OS Fund

    & 7 more

  • Employee Count
    33

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of uBiome

uBiome has successfully raised a total of $109.62M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $83 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series C — $83.0M
  • First Round
  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2018 Amount Series C - uBiome Valuation OS Fund
Nov, 2016 Amount Series B - uBiome Valuation 8VC
Aug, 2014 Amount Series A - uBiome Valuation a16z

Investors in uBiome

uBiome has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include OS Fund, 8VC and Y Combinator.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage centric sector-agnostic VC firm investing in geographies such as the US
Founded Year Domain Location
Venture capital firm investing in technology, life sciences, and related sectors.
Founded Year Domain Location
Early-stage startups are accelerated via funding and educational programs.
Founded Year Domain Location

Investments & Acquisitions by uBiome

Investments

Financial Statements - uBiome

Ubiome Comparisons

+
Add Comparison
Available on Premium

Competitors of uBiome

uBiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Seed, Azitra, Flore and Evvy, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Machine learning-based bioinformatics solutions for health insights are provided.
domain founded_year HQ Location
Synbiotics are developed for simulating the gut microbiome.
domain founded_year HQ Location
Microbiome-based therapeutics for skin conditions like eczema are developed.
domain founded_year HQ Location
Customized probiotics for gut health are provided via stool analysis.
domain founded_year HQ Location
Vaginal microbiome test kits are provided through an online platform.
domain founded_year HQ Location
AI-enabled platform for microbiome data generation and analysis is developed.

Latest news on Ubiome

Frequently Asked Questions about uBiome

uBiome was founded in 2012 and raised its 1st funding round 1 year after it was founded.

uBiome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Jessica Richman is the current CEO of uBiome. They have also founded this company.

uBiome is a funded company, having raised a total of $109.62M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.5M, raised on Oct 30, 2013.

As of Dec 31, 2022, the latest employee count at uBiome is 33.

uBiome, founded in 2012 in San Francisco, United States, focuses on providing healthcare solutions, advancing biotech innovations, microbiome analysis, and data sequencing. Provides comprehensive sequence datasets for human microbiome research and analysis. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

uBiome's top competitors include Viome, Azitra and Seed.

uBiome has 8 investors. Key investors include OS Fund, 8VC, Y Combinator, Dentsu Ventures, and Slow Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available